Page results
-
This page tells you about the procedure known as a renal cryoablation. It explains what is involved and what the possible risks are.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
The children and young people's division at UCLH are running two events for young people aged 13 - 24 years.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
File results
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0115 - Patient feeding and retail catering
-
FOI/2022/0119 - Chemotherapy for patients with osteosarcoma
-
FOI/2022/0123 - Sexual assault allegations in care settings
-
FOI/2022/0124 - Clinical service incidents caused by estates and infrastructure failure
-
FOI/2022/0127 - Provision for treatment of Functional Neurological Disorder (FND)
-
FOI/2022/0134 - Plastic laminating pouches/ sleeves purchased
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments